Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study
…, P O'hara, GR Owens, PD Scanlon, DP Tashkin… - Jama, 1994 - jamanetwork.com
Objective. —To determine whether a program incorporating smoking intervention and use
of an inhaled bronchodilator can slow the rate of decline in forced expiratory volume in 1 …
of an inhaled bronchodilator can slow the rate of decline in forced expiratory volume in 1 …
[HTML][HTML] A 4-year trial of tiotropium in chronic obstructive pulmonary disease
Background Previous studies showing that tiotropium improves multiple end points in
patients with chronic obstructive pulmonary disease (COPD) led us to examine the long-term …
patients with chronic obstructive pulmonary disease (COPD) led us to examine the long-term …
[HTML][HTML] Cyclophosphamide versus placebo in scleroderma lung disease
DP Tashkin, R Elashoff, PJ Clements… - … England Journal of …, 2006 - Mass Medical Soc
Background We conducted a double-blind, randomized, placebo-controlled trial to determine
the effects of oral cyclophosphamide on lung function and health-related symptoms in …
the effects of oral cyclophosphamide on lung function and health-related symptoms in …
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group …
DP Tashkin, MD Roth, PJ Clements… - The lancet Respiratory …, 2016 - thelancet.com
Background 12 months of oral cyclophosphamide has been shown to alter the progression
of scleroderma-related interstitial lung disease when compared with placebo. However, …
of scleroderma-related interstitial lung disease when compared with placebo. However, …
[HTML][HTML] Clinical significance of symptoms in smokers with preserved pulmonary function
…, R Paine III, S Rennard, DP Tashkin… - … England Journal of …, 2016 - Mass Medical Soc
Background Currently, the diagnosis of chronic obstructive pulmonary disease (COPD)
requires a ratio of forced expiratory volume in 1 second (FEV 1 ) to forced vital capacity (FVC) of …
requires a ratio of forced expiratory volume in 1 second (FEV 1 ) to forced vital capacity (FVC) of …
Pulmonary hazards of smoking marijuana as compared with tobacco
TC Wu, DP Tashkin, B Djahed… - New England Journal of …, 1988 - Mass Medical Soc
To compare the pulmonary hazards of smoking marijuana and tobacco, we quantified the
relative burden to the lung of insoluble particulates (tar) and carbon monoxide from the smoke …
relative burden to the lung of insoluble particulates (tar) and carbon monoxide from the smoke …
Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised …
Background The beneficial effects of pharmacotherapy for chronic obstructive pulmonary
disease (COPD) are well established. However, there are few data for treatment in the early …
disease (COPD) are well established. However, there are few data for treatment in the early …
An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease
…, DD Sin, JB Soriano, JK Stoller, DP Tashkin… - American journal of …, 2015 - atsjournals.org
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity,
mortality, and resource use worldwide. The goal of this Official American Thoracic Society (…
mortality, and resource use worldwide. The goal of this Official American Thoracic Society (…
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease
DP Tashkin, R Elashoff, PJ Clements… - American journal of …, 2007 - atsjournals.org
… Correspondence and requests for reprints should be addressed to Donald P. Tashkin, MD,
Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, 10833 …
Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, 10833 …
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease
…, JE Connett, NR Anthonisen, RA Wise, DP Tashkin… - Thorax, 2006 - thorax.bmj.com
Background: Although C-reactive protein (CRP) levels are increased in chronic obstructive
pulmonary disease (COPD), it is not certain whether they are associated with adverse clinical …
pulmonary disease (COPD), it is not certain whether they are associated with adverse clinical …